| Sheila Owens, MD | |
|
2609 Glenn Hendren Dr, Liberty, MO 64068-3313 | |
| (816) 781-7730 | |
| (816) 415-1886 |
| Full Name | Sheila Owens |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 12 Years |
| Location | 2609 Glenn Hendren Dr, Liberty, Missouri |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245592906 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 2015018630 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| New Liberty Hospital District | Liberty, MO | Hospital |
| North Kansas City Hospital | North kansas city, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| New Liberty Hospital Corporation | 9931166618 | 95 |
| Select Physical Therapy Holdings Inc | 9537076401 | 1487 |
News Archive
SensAble Technologies, Inc®, a leading provider of 3D modeling solutions and haptic devices, announced that its customer, Kallisto, a provider of 3D technologies as well as rapid prototyping and manufacturing solutions to the orthotics and prosthetics industry, is showcasing a major new version of its BYOSYS® solution at Europe's leading industry event, the Orthopädie + Reha-Technik show, which opened in Leipzig, Germany today.
Albireo AB, a biopharmaceutical company specializing in gastroenterology, today announced that A4250 (an inhibitor of the ileal bile acid transporter, IBAT/ASBT) has been granted orphan-drug designation by the U.S Food and Drug Administration for the treatment of Progressive Familial Intrahepatic Cholestasis (PFIC) and Primary Biliary Cirrhosis (PBC).
Discovery Laboratories, Inc. today announced the presentation of a new pharmacoeconomic analysis demonstrating that the lower rate of reintubation previously reported in infants treated with SURFAXIN, when compared with infants treated with Curosurf® and Survanta®, the current global market leading surfactants, also resulted in a potential hospital cost savings of $160,000 to $252,000 per 100 infants.
A new study from the University of Birmingham has presented evidence that could settle the debate over whether people can be obese and healthy at the same time.
Quest Products, Inc. announces the national launch of ProVent® Rosacea Moisturizing Creme®, a creme formulated to help reduce the appearance of skin conditions often associated with Rosacea, and other skin conditions, including skin redness, age spots, facial rashes, dry skin, and sun-related damage.
› Verified 4 days ago
| Entity Name | New Liberty Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1669734661 PECOS PAC ID: 9931166618 Enrollment ID: O20120918000321 |
News Archive
SensAble Technologies, Inc®, a leading provider of 3D modeling solutions and haptic devices, announced that its customer, Kallisto, a provider of 3D technologies as well as rapid prototyping and manufacturing solutions to the orthotics and prosthetics industry, is showcasing a major new version of its BYOSYS® solution at Europe's leading industry event, the Orthopädie + Reha-Technik show, which opened in Leipzig, Germany today.
Albireo AB, a biopharmaceutical company specializing in gastroenterology, today announced that A4250 (an inhibitor of the ileal bile acid transporter, IBAT/ASBT) has been granted orphan-drug designation by the U.S Food and Drug Administration for the treatment of Progressive Familial Intrahepatic Cholestasis (PFIC) and Primary Biliary Cirrhosis (PBC).
Discovery Laboratories, Inc. today announced the presentation of a new pharmacoeconomic analysis demonstrating that the lower rate of reintubation previously reported in infants treated with SURFAXIN, when compared with infants treated with Curosurf® and Survanta®, the current global market leading surfactants, also resulted in a potential hospital cost savings of $160,000 to $252,000 per 100 infants.
A new study from the University of Birmingham has presented evidence that could settle the debate over whether people can be obese and healthy at the same time.
Quest Products, Inc. announces the national launch of ProVent® Rosacea Moisturizing Creme®, a creme formulated to help reduce the appearance of skin conditions often associated with Rosacea, and other skin conditions, including skin redness, age spots, facial rashes, dry skin, and sun-related damage.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sheila Owens, MD Po Box 219672, Kansas City, MO 64121-9672 Ph: (816) 781-7730 | Sheila Owens, MD 2609 Glenn Hendren Dr, Liberty, MO 64068-3313 Ph: (816) 781-7730 |
News Archive
SensAble Technologies, Inc®, a leading provider of 3D modeling solutions and haptic devices, announced that its customer, Kallisto, a provider of 3D technologies as well as rapid prototyping and manufacturing solutions to the orthotics and prosthetics industry, is showcasing a major new version of its BYOSYS® solution at Europe's leading industry event, the Orthopädie + Reha-Technik show, which opened in Leipzig, Germany today.
Albireo AB, a biopharmaceutical company specializing in gastroenterology, today announced that A4250 (an inhibitor of the ileal bile acid transporter, IBAT/ASBT) has been granted orphan-drug designation by the U.S Food and Drug Administration for the treatment of Progressive Familial Intrahepatic Cholestasis (PFIC) and Primary Biliary Cirrhosis (PBC).
Discovery Laboratories, Inc. today announced the presentation of a new pharmacoeconomic analysis demonstrating that the lower rate of reintubation previously reported in infants treated with SURFAXIN, when compared with infants treated with Curosurf® and Survanta®, the current global market leading surfactants, also resulted in a potential hospital cost savings of $160,000 to $252,000 per 100 infants.
A new study from the University of Birmingham has presented evidence that could settle the debate over whether people can be obese and healthy at the same time.
Quest Products, Inc. announces the national launch of ProVent® Rosacea Moisturizing Creme®, a creme formulated to help reduce the appearance of skin conditions often associated with Rosacea, and other skin conditions, including skin redness, age spots, facial rashes, dry skin, and sun-related damage.
› Verified 4 days ago
Dr. Mitzi E Mathews, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2609 Glenn Hendren Drive, Liberty, MO 64068 Phone: 816-781-7730 Fax: 816-415-1886 | |
Dr. Jordan Haskins, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2525 Glenn Hendren Dr, Liberty, MO 64068 Phone: 816-781-7200 | |
Adam Lee Harrold, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2609 Glenn Hendren Dr, Liberty, MO 64068 Phone: 816-781-7730 Fax: 816-781-6973 | |
Dr. Steven Christopher Nelson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 140 Westwoods Dr, Liberty, MO 64068 Phone: 816-781-4740 Fax: 816-781-0971 | |
Kyle Schneweis, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2609 Glenn Hendren Dr, Liberty, MO 64068 Phone: 816-781-7730 Fax: 816-781-6973 | |
Dr. Amy Elisabeth Parry, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9 Victory Dr, Liberty, MO 64068 Phone: 816-792-1809 Fax: 816-792-1860 |